All Updates

All Updates

icon
Filter
Funding
ExpressionEdits raises USD 13 million in seed funding for development and preclinical studies of protein-based therapeutics
AI Drug Discovery
May 29, 2024
This week:
Funding
GrayMatter Robotics raises USD 45 million in Series B funding to accelerate AI-powered robotics solutions
Smart Factory
Jun 20, 2024
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Logistics Tech
Jun 20, 2024
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Smart Factory
Jun 20, 2024
Funding
FairNow raises USD 3.5 million to advance AI governance solutions
Generative AI Infrastructure
Jun 20, 2024
Partnerships
Gravitics develops testing gauntlet for larger spacecraft in collaboration with NASA
Space Travel and Exploration Tech
Jun 20, 2024
M&A
knownwell acquires Alfie Health to integrate AI in primary and obesity care services
Telehealth
Jun 20, 2024
Funding
Pomelo Care raises USD 46 million in Series B funding to expand virtual maternal care
Telehealth
Jun 20, 2024
Funding
Isar Aerospace raises EUR 65 million, backed by NATO Innovation Fund
Space Travel and Exploration Tech
Jun 20, 2024
Product updates
Beyond Meat releases new Beyond Sausage, expanding its Beyond IV product line
Plant-based Meat
Jun 20, 2024
Product updates
Funding
SurrealDB raises USD 20 million in Series A; launches beta version of Surreal Cloud
Data Infrastructure & Analytics
Jun 20, 2024
AI Drug Discovery

AI Drug Discovery

May 29, 2024

ExpressionEdits raises USD 13 million in seed funding for development and preclinical studies of protein-based therapeutics

Funding

  • AI-powered biotechnology company ExpressionEdits has raised USD 13 million in a seed funding round led by Octopus Ventures and redalpine, with contributions from BlueYard Capital and Wilbe Capital, among others.

  • The proceeds will be directed toward accelerating candidate selection for the company’s ongoing preclinical studies and developing its pipeline of protein-based therapeutics, with a focus on recombinant proteins faced with manufacturing challenges based on current technology.

  • ExpressionEdits is a cutting-edge company that optimizes gene design through its unique intronization technology. This approach manipulates the genetic structure by integrating multiple short noncoding DNA sections, advancing gene expression and leading to improved protein production.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.